Multiple-ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD9977 in healthy male subjects

Trial Identifier:	D6401C00001
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT03435276
Start Date:	February 2018
Primary Completion Date:	June 2018
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.